Variant report

Variant	nsv432489
Chromosome Location	chr3:146271370-146323969
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:784)
CpG islands
(count:122)
Chromatin interactive
region (count:22)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:784 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:146298569-146299608	HepG2	liver:	n/a	n/a
2	ARID3A	chr3:146272010-146272659	K562	blood:	n/a	n/a
3	ARID3A	chr3:146295512-146295811	HepG2	liver:	n/a	n/a
4	ARID3A	chr3:146307695-146308076	HepG2	liver:	n/a	n/a
5	ARID3A	chr3:146307731-146307972	K562	blood:	n/a	n/a
6	ARID3A	chr3:146312705-146312962	K562	blood:	n/a	n/a
7	ARID3A	chr3:146312658-146313055	HepG2	liver:	n/a	chr3:146312670-146312686
8	ARID3A	chr3:146295541-146295811	K562	blood:	n/a	n/a
9	ATF1	chr3:146271999-146272580	K562	blood:	n/a	n/a
10	ATF1	chr3:146274050-146274245	K562	blood:	n/a	n/a
11	ATF1	chr3:146299931-146300152	K562	blood:	n/a	n/a
12	BHLHE40	chr3:146271940-146272263	GM12878	blood:	n/a	n/a
13	BHLHE40	chr3:146288926-146288937	K562	blood:	n/a	n/a
14	BHLHE40	chr3:146275473-146275840	K562	blood:	n/a	n/a
15	BHLHE40	chr3:146298822-146299312	HepG2	liver:	n/a	n/a
16	BHLHE40	chr3:146271923-146272586	K562	blood:	n/a	n/a
17	CBX3	chr3:146272224-146272554	K562	blood:	n/a	n/a
18	CBX3	chr3:146307720-146308105	HCT-116	colon:	n/a	n/a
19	CCNT2	chr3:146272301-146272540	K562	blood:	n/a	chr3:146272480-146272500
20	CCNT2	chr3:146278498-146278775	K562	blood:	n/a	n/a
21	CCNT2	chr3:146310621-146310943	K562	blood:	n/a	n/a
22	CEBPB	chr3:146299996-146300128	K562	blood:	n/a	n/a
23	CEBPB	chr3:146279672-146280016	HCT-116	colon:	n/a	n/a
24	CEBPB	chr3:146272319-146272499	K562	blood:	n/a	n/a
25	CEBPB	chr3:146284384-146284732	HepG2	liver:	n/a	chr3:146284539-146284550
26	CEBPB	chr3:146279710-146279967	K562	blood:	n/a	n/a
27	CEBPB	chr3:146286212-146286363	A549	lung:	n/a	n/a
28	CEBPB	chr3:146272286-146272540	H1-hESC	embryonic stem cell:	n/a	n/a
29	CEBPB	chr3:146279689-146280026	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr3:146272238-146272549	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr3:146271855-146272609	K562	blood:	n/a	n/a
32	CEBPB	chr3:146298901-146299092	HepG2	liver:	n/a	chr3:146299021-146299038
33	CEBPB	chr3:146272166-146272605	K562	blood:	n/a	n/a
34	CEBPB	chr3:146306924-146307111	K562	blood:	n/a	chr3:146307049-146307062
35	CEBPB	chr3:146299890-146300141	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr3:146284673-146284675	H1-hESC	embryonic stem cell:	n/a	n/a
37	CEBPB	chr3:146298851-146299312	HepG2	liver:	n/a	chr3:146299021-146299038
38	CEBPB	chr3:146279573-146280115	HCT-116	colon:	n/a	n/a
39	CEBPB	chr3:146272240-146272577	IMR90	lung:	n/a	n/a
40	CHD2	chr3:146299921-146300178	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr3:146307820-146307970	WERI-Rb-1	eye:	n/a	n/a
42	CTCF	chr3:146295580-146295730	K562	blood:	n/a	n/a
43	CTCF	chr3:146307820-146307970	AoAF	blood vessel:	n/a	n/a
44	CTCF	chr3:146277837-146277928	Lung_OC	lung:	n/a	n/a
45	CTCF	chr3:146295560-146295710	HVMF	connective:	n/a	n/a
46	CTCF	chr3:146284186-146284206	GM13976	blood:	n/a	n/a
47	CTCF	chr3:146307820-146307970	GM12872	blood:	n/a	n/a
48	CTCF	chr3:146312561-146312969	HCT-116	colon:	n/a	n/a
49	CTCF	chr3:146313300-146313450	HA-sp	spinal cord:	n/a	n/a
50	CTCF	chr3:146312822-146312904	Lung_OC	lung:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:146323078-146323128	GM19239	blood:	n/a
2	chr3:146302692-146302742	CMK	blood:	n/a
3	chr3:146323078-146323128	NH-A	brain:	n/a
4	chr3:146323078-146323128	AG04450	lung:	fetal
5	chr3:146302692-146302742	AG09309	skin:	n/a
6	chr3:146302692-146302742	NT2-D1	testis:	n/a
7	chr3:146302692-146302742	GM12891	blood:	n/a
8	chr3:146302692-146302742	AG09319	gingival:	n/a
9	chr3:146302692-146302742	GM12878	blood:	n/a
10	chr3:146323078-146323128	GM12891	blood:	n/a
11	chr3:146323078-146323128	BJ	skin:	n/a
12	chr3:146323078-146323128	SKMC	muscle:	n/a
13	chr3:146302692-146302742	NHBE	bronchial:	n/a
14	chr3:146323078-146323128	HCM	heart:	n/a
15	chr3:146323078-146323128	AG09319	gingival:	n/a
16	chr3:146302692-146302742	BE2_C	brain:	n/a
17	chr3:146323078-146323128	NT2-D1	testis:	n/a
18	chr3:146302692-146302742	GM19239	blood:	n/a
19	chr3:146323078-146323128	HAEpiC	amniotic membrane:	n/a
20	chr3:146302692-146302742	SK-N-MC	brain:	n/a
21	chr3:146302692-146302742	AG10803	skin:	n/a
22	chr3:146323078-146323128	ovcar-3	ovarian:	n/a
23	chr3:146302692-146302742	PrEC	prostate:	n/a
24	chr3:146323078-146323128	Hepatocyte	liver:	n/a
25	chr3:146323078-146323128	HepG2	liver:	n/a
26	chr3:146302692-146302742	LNCaP	prostate:	n/a
27	chr3:146302692-146302742	MCF-7	breast:	n/a
28	chr3:146302692-146302742	SAEC	small airway:	n/a
29	chr3:146302692-146302742	T-47D	breast:	n/a
30	chr3:146323078-146323128	MCF-7	breast:	n/a
31	chr3:146323078-146323128	HL-60	blood:	n/a
32	chr3:146323078-146323128	HMEC	breast:	n/a
33	chr3:146323078-146323128	NHBE	bronchial:	n/a
34	chr3:146302692-146302742	PFSK-1	brain:	n/a
35	chr3:146323078-146323128	RPTEC	kidney:	n/a
36	chr3:146302692-146302742	Jurkat	blood:	n/a
37	chr3:146323078-146323128	K562	blood:	n/a
38	chr3:146302692-146302742	HIPEpiC	eye:	n/a
39	chr3:146302692-146302742	K562	blood:	n/a
40	chr3:146302692-146302742	RPTEC	kidney:	n/a
41	chr3:146323078-146323128	PANC-1	pancreas:	n/a
42	chr3:146323078-146323128	SK-N-MC	brain:	n/a
43	chr3:146323078-146323128	Hela-S3	cervix:	n/a
44	chr3:146302692-146302742	HAEpiC	amniotic membrane:	n/a
45	chr3:146323078-146323128	PrEC	prostate:	n/a
46	chr3:146323078-146323128	A549	lung:	n/a
47	chr3:146323078-146323128	HCT-116	colon:	n/a
48	chr3:146302692-146302742	ProgFib	skin:	n/a
49	chr3:146302692-146302742	SKMC	muscle:	n/a
50	chr3:146302692-146302742	HEK293	kidney:	embryo

(count:22 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:146271238..146272788-chr3:146273946..146275885,2	K562	blood:
2	chr3:146307443..146308365-chr3:146356345..146357148,6	MCF-7	breast:
3	chr3:146259917..146263549-chr3:146271246..146274873,4	MCF-7	breast:
4	chr3:146254472..146257270-chr3:146278262..146280124,2	K562	blood:
5	chr3:146307488..146308559-chr3:146358352..146359232,4	MCF-7	breast:
6	chr3:145936710..145937294-chr3:146312292..146312926,2	K562	blood:
7	chr3:146296197..146299106-chr3:146299560..146302239,2	K562	blood:
8	chr3:146053792..146056507-chr3:146270955..146273271,2	K562	blood:
9	chr3:146271238..146272788-chr3:146273946..146275885,2	K562	blood:
10	chr3:145936366..145937318-chr3:146295230..146296148,3	K562	blood:
11	chr3:146254083..146256051-chr3:146272994..146275921,2	MCF-7	breast:
12	chr3:146044616..146045587-chr3:146295200..146296047,4	MCF-7	breast:
13	chr3:146261061..146263608-chr3:146270616..146272479,2	MCF-7	breast:
14	chr3:145783012..145783944-chr3:146295169..146296067,2	K562	blood:
15	chr3:146051675..146052565-chr3:146295209..146295722,2	MCF-7	breast:
16	chr3:146268773..146270653-chr3:146270880..146272451,2	K562	blood:
17	chr3:146245158..146247754-chr3:146270114..146271992,2	K562	blood:
18	chr3:146051922..146052597-chr3:146295303..146296107,2	MCF-7	breast:
19	chr3:146261206..146264075-chr3:146277195..146279584,2	K562	blood:
20	chr3:145940254..145941134-chr3:146295120..146295978,3	MCF-7	breast:
21	chr3:146312409..146312943-chr3:146358371..146359105,2	MCF-7	breast:
22	chr3:146296197..146299106-chr3:146299560..146302239,2	K562	blood:

No data

Variant related genes	Relation type
PLSCR5-AS1	TF binding region
RNU6-428P	TF binding region
PLSCR5	TF binding region
PLSCR5-AS1	CpG island
RNU6-428P	CpG island
PLSCR5	CpG island
ENSG00000188313	chromatin interactions

Extended variants
information (count: 2004 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:2004 , 50 per page) page: 1 2 3 4 5 6 7 ... 41

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13074501	chr3:146271370-146271371	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs557233232	chr3:146271413-146271414	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs369235441	chr3:146271455-146271456	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs373955661	chr3:146271476-146271477	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs575733890	chr3:146271525-146271526	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs561659820	chr3:146271559-146271560	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs138698686	chr3:146271578-146271579	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs150019845	chr3:146271595-146271596	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs72034960	chr3:146271600-146271601	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs374608364	chr3:146271601-146271602	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs142325945	chr3:146271602-146271603	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs9860579	chr3:146271641-146271642	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs192449220	chr3:146271647-146271648	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs183784999	chr3:146271679-146271680	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs564837795	chr3:146271684-146271685	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs187054851	chr3:146271692-146271693	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs550790317	chr3:146271703-146271704	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs190336118	chr3:146271718-146271719	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs537761940	chr3:146271740-146271741	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs9861142	chr3:146271762-146271763	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs372976784	chr3:146271774-146271775	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs146336822	chr3:146271776-146271777	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs72994220	chr3:146271796-146271797	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs113326304	chr3:146271810-146271811	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs571979845	chr3:146271882-146271883	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs538955183	chr3:146271902-146271903	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs557580432	chr3:146271922-146271923	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs139238290	chr3:146271978-146271979	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs536789716	chr3:146272055-146272056	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs117672885	chr3:146272077-146272078	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs572975623	chr3:146272116-146272117	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs149563228	chr3:146272161-146272162	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs564926147	chr3:146272189-146272190	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs577112883	chr3:146272196-146272197	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs569997527	chr3:146272209-146272210	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs182535731	chr3:146272215-146272216	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs376998587	chr3:146272247-146272248	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs553143600	chr3:146272249-146272250	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs17431420	chr3:146272269-146272270	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs187179587	chr3:146272273-146272274	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs548337081	chr3:146272383-146272384	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs560294403	chr3:146272421-146272422	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs527342684	chr3:146272423-146272424	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs4629301	chr3:146272427-146272428	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs9865918	chr3:146272461-146272462	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs112998023	chr3:146272483-146272484	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs77218111	chr3:146272486-146272487	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs144368455	chr3:146272491-146272492	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs550979487	chr3:146272492-146272493	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs72994222	chr3:146272495-146272496	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
Colorectal cancer	18645599	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Mental retardation	17847001	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Autism	18923514	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Autism	21956041	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:194 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:146263800-146271800	Weak transcription	K562	blood
2	chr3:146267200-146271600	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr3:146267800-146272000	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr3:146268200-146272200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
5	chr3:146268600-146271600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
6	chr3:146268800-146272400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr3:146269000-146272000	Weak transcription	HUES48 Cell Line	embryonic stem cell
8	chr3:146269200-146271400	Weak transcription	Dnd41	blood
9	chr3:146269200-146271800	Weak transcription	A549	lung
10	chr3:146269200-146273200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
11	chr3:146269400-146272000	Weak transcription	Placenta Amnion	Placenta Amnion
12	chr3:146269600-146271600	Weak transcription	GM12878-XiMat	blood
13	chr3:146270000-146284000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr3:146270200-146274200	Weak transcription	HMEC	breast
15	chr3:146271000-146271400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
16	chr3:146271000-146271800	Enhancers	Monocytes-CD14+_RO01746	blood
17	chr3:146271200-146271600	Enhancers	Primary B cells from cord blood	blood
18	chr3:146271200-146272600	Enhancers	Primary monocytes fromperipheralblood	blood
19	chr3:146271400-146272200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr3:146271400-146272400	Enhancers	Dnd41	blood
21	chr3:146271600-146271800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr3:146271600-146272400	Active TSS	Primary B cells from cord blood	blood
23	chr3:146271600-146272600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
24	chr3:146271600-146272600	Enhancers	Primary hematopoietic stem cells short term culture	blood
25	chr3:146271800-146272000	Enhancers	GM12878-XiMat	blood
26	chr3:146271800-146272200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
27	chr3:146271800-146272600	Enhancers	K562	blood
28	chr3:146271800-146272800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr3:146272000-146272400	Enhancers	H1 Cell Line	embryonic stem cell
30	chr3:146272000-146272400	Enhancers	Placenta Amnion	Placenta Amnion
31	chr3:146272000-146272600	Enhancers	HUES48 Cell Line	embryonic stem cell
32	chr3:146272200-146272600	Enhancers	ES-I3 Cell Line	embryonic stem cell
33	chr3:146272200-146272600	Enhancers	Monocytes-CD14+_RO01746	blood
34	chr3:146272200-146275600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
35	chr3:146272400-146273200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr3:146272400-146275600	Weak transcription	Primary B cells from cord blood	blood
37	chr3:146272600-146275200	Weak transcription	Monocytes-CD14+_RO01746	blood
38	chr3:146272600-146275400	Weak transcription	Primary monocytes fromperipheralblood	blood
39	chr3:146272600-146275400	Enhancers	Primary neutrophils fromperipheralblood	blood
40	chr3:146272600-146275400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
41	chr3:146272800-146274600	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr3:146273200-146273600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
43	chr3:146273200-146274000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr3:146274200-146274600	Enhancers	HMEC	breast
45	chr3:146275200-146275600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr3:146275200-146276400	Enhancers	Monocytes-CD14+_RO01746	blood
47	chr3:146275400-146275800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
48	chr3:146275400-146277400	Enhancers	Primary monocytes fromperipheralblood	blood
49	chr3:146275400-146277400	Enhancers	Primary hematopoietic stem cells short term culture	blood
50	chr3:146275600-146275800	ZNF genes & repeats	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links